Freed launches Clinical Evidence, a tool that provides ad-free clinical answers tailored to the patient in the room. It answers clinical questions using cited medical literature and carries no advertising.
Freed says 20,000 paying clinicians use its medical AI transcription scribe, marking the company's reported usage growth. Its chief executive discusses the product's pricing and a competitive landscape that is rising fast as new medical AI scribe products enter the market.
Freed, a San Francisco-based company, raises $30 million in a Series A led by Sequoia Capital to develop its AI medical scribe and expand its clinician base. The product records patient visits and automatically drafts clinical notes, targeting the documentation burden that contributes to clinician burnout. Freed says the financing will support product development and expansion.
Freed closes a $30 million Series A led by Sequoia Capital, bringing its total funding to $34 million. The company develops an AI-based clinician assistant.
